Researchers from Washington University School of Medicine and Stanford University have developed a compound that simulates a ...
When faced with chronic stress, why do some people develop anxiety and depressive symptoms while others show resilience? A protein that acts as a cannabinoid receptor and is present in the structure ...
In a new step forward on the quest for better painkillers, scientists have developed a synthetic cannabinoid that keeps the ...
The study is published March 5 in Nature. “There is an urgent need to develop ... natural molecules found in the cannabis ...
Researchers at Washington University and Stanford developed a cannabinoid compound that provides pain relief without ...
The drug, known as VIP36, targets the body’s cannabinoid receptor type 1 (CB1). It was found to be effective in three ...
Researchers create a cannabis-derived compound that relieves pain without the risk of addiction or mind-altering effects.
Synthetic cannabinoids, a class of new psychoactive substances, bind to cannabinoid receptors CB1 and CB2 much more strongly than tetrahydrocannabinol (THC) and cannabidiol (CBD), raising public ...